Gravar-mail: Synergistic Neutralization of Simian-Human Immunodeficiency Virus SHIV-vpu(+) by Triple and Quadruple Combinations of Human Monoclonal Antibodies and High-Titer Anti-Human Immunodeficiency Virus Type 1 Immunoglobulins